Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Statin Cost-Effectiveness in t...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels
Bibliographic Details
Main Authors:
Mihaylova, B
,
Briggs, A
,
Hlatky, M
,
Armitage, J
,
Parish, S
,
Gray, A
,
Collins, R
,
Study, HP
Format:
Journal article
Published:
2009
Holdings
Description
Similar Items
Staff View
Description
Summary:
Similar Items
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
by: Mihaylova, B, et al.
Published: (2005)
Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
by: Mihaylova, B, et al.
Published: (2005)
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
by: Mihaylova, B, et al.
Published: (2006)
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
by: Mihaylova, B, et al.
Published: (2024)
The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
by: Kent, S, et al.
Published: (2016)